Get started
Author

Caro Noake

Observed names: C Noake, C. Noake, Noake, C., Noake, Caro
ORCID: 0000-0003-0329-4772
Observed ORCID: 0000-0003-0329-4772
OpenAlex ID: A5051240644
Rapid fetal fibronectin testing to predict preterm birth in women with symptoms of premature labour: a systematic review and cost analysis
2013 · SN Deshpande, ADI van Asselt, et al. · Health Technology Assessment · 241
PDF
KRAS mutation testing of tumours in adults with metastatic colorectal cancer: a systematic review and cost-effectiveness analysis
2014 · Marie Westwood, Thea van Asselt, et al. · Health Technology Assessment · 86
ImmunoCAP® ISAC and Microtest for multiplex allergen testing in people with difficult to manage allergic disease: a systematic review and cost analysis
2016 · Marie Westwood, Bram Ramaekers, et al. · Health Technology Assessment · 51
PDF
SeHCAT [tauroselcholic (selenium-75) acid] for the investigation of bile acid malabsorption and measurement of bile acid pool loss: a systematic review and cost-effectiveness analysis
2013 · R Riemsma, M Al, et al. · Health Technology Assessment · 48
PDF
Supplementary searches of PubMed to improve currency of MEDLINE and MEDLINE In-Process searches via Ovid
2016 · Steven Duffy, Shelley de Kock, et al. · Journal of the Medical Library Association JMLA · 35
Systematic review search methods evaluated using the Preferred Reporting of Items for Systematic Reviews and Meta-Analyses and the Risk Of Bias In Systematic reviews tool
2020 · Shelley de Kock, Lisa Stirk, et al. · International Journal of Technology Assessment in Health Care · 24
Software with artificial intelligence-derived algorithms for analysing CT brain scans in people with a suspected acute stroke: a systematic review and cost-effectiveness analysis
2024 · Marie Westwood, Bram Ramaekers, et al. · Health Technology Assessment · 21
PDF
Systematic review and network meta-analysis of the efficacy and safety of lidocaine 700 mg medicated plaster vs. pregabalin
2019 · Titas Buksnys, Nigel Armstrong, et al. · Current Medical Research and Opinion · 21
Fluocinolone Acetonide Intravitreal Implant for Treating Recurrent Non-infectious Uveitis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
2019 · Xavier G. L. V. Pouwels, Svenja Petersohn, et al. · PharmacoEconomics · 19
PDF
A systematic review of clinical effectiveness and safety for historical and current treatment options for metachromatic leukodystrophy in children, including atidarsagene autotemcel
2023 · Nigel Armstrong, Andrew Olaye, et al. · Orphanet Journal of Rare Diseases · 15
PDF
Digital interventions to moderate physical inactivity and/or nutrition in young people: a Cancer Prevention Europe overview of systematic reviews
2023 · Kevin T. McDermott, Caro Noake, et al. · Frontiers in Digital Health · 13
Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) checklist
2013 · SN Deshpande, Adi van Asselt, et al. · 12
Ixekizumab for Treating Moderate-to-Severe Plaque Psoriasis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
2018 · Bram L. T. Ramaekers, Robert F. Wolff, et al. · PharmacoEconomics · 11
PDF
Digital interventions to moderate alcohol consumption in young people: a Cancer Prevention Europe overview of systematic reviews
2023 · Kevin T. McDermott, Caro Noake, et al. · Frontiers in Digital Health · 10
PDF
Pembrolizumab for Treating Relapsed or Refractory Classical Hodgkin Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
2019 · Sabine E. Grimm, Debra Fayter, et al. · PharmacoEconomics · 10
PDF
Preferred Reporting Items for Systematic Reviews and Meta-Analyses checklist
2013 · Marie Westwood, Thea van Asselt, et al. · 6
KardiaMobile 6L for measuring QT interval in people having antipsychotic medication to inform early value assessment: a systematic review
2024 · Marie Westwood, Nigel Armstrong, et al. · Health Technology Assessment · 4
PDF
Lenalidomide for the Treatment of Low- or Intermediate-1-Risk Myelodysplastic Syndromes Associated with Deletion 5q Cytogenetic Abnormality: An Evidence Review of the NICE Submission from Celgene
2015 · Hedwig M. Blommestein, Nigel Armstrong, et al. · PharmacoEconomics · 4
PDF
A cloud-based medical device for predicting cardiac risk in suspected coronary artery disease: a rapid review and conceptual economic model
2024 · Marie Westwood, Nigel Armstrong, et al. · Health Technology Assessment · 3
PDF
Oral Azacitidine for Maintenance Treatment of Acute Myeloid Leukaemia After Induction Therapy: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
2023 · Willem Witlox, Sabine Grimm, et al. · PharmacoEconomics · 3
PDF
Response to Comment on “Fluocinolone Acetonide Intravitreal Implant for Treating Recurrent Non-Infectious Uveitis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal”
2020 · Xavier G. L. V. Pouwels, Svenja Petersohn, et al. · PharmacoEconomics · 3
PDF
Pmu6 Systematic Review of the Efficacy and Safety of 5% Lidocaine-medicated Plaster Vs. Pregabalin
2019 · S. Ryder, T. Buksnys, et al. · Value in Health · 3
PDF
Supplementary searches of PubMed to improve currency of MEDLINE and MEDLINE In-Process searches via Ovid
2017 · Steven Duffy, Shelley De Kock, et al. · Journal of the Medical Library Association JMLA · 3
PDF
Bayesian Hierarchical Modelling for Histology-Independent Time-to-Event Outcomes in the NICE Single Technology Appraisal of Pembrolizumab for Solid Tumours with MSI-H/dMMR: External Assessment Group Perspective
2024 · Bradley M. Sugden, Sabine E. Grimm, et al. · PharmacoEconomics · 2
SeHCAT (tauroselcholic [75selenium] acid) for the investigation of bile acid diarrhoea in adults: a systematic review and cost-effectiveness analysis
2022 · Marie Westwood, Isaac Corro Ramos, et al. · Health Technology Assessment · 2
PDF
Works count: 59
Citation count: 653
H-index: 12
I10-index: 15
Year
Topic
Type